Tricyclic spiro derivatives as CRTH2 modulators
US8236963B2 · kind B2 · utility
5Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2006 |
| Grant date | Aug 7, 2012 |
| Priority date | — |
| Expiry date | Mar 30, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.